Lead Plaintiff, Lead Counsel Appointed In Securities Class Action

Lead Plaintiff, Lead Counsel Appointed In Securities Class Action

WASHINGTON, D.C. - A federal judge in the District of Columbia on Dec. 4 appointed a shareholder as lead plaintiff in a securities class action lawsuit against a pharmaceutical company and certain of its senior officers, ruling that the shareholder has met all requirements to serve in the role (Jeff Small v. Vanda Pharmaceuticals Inc., et al., No. 13-955, D. D.C.; Tuan Hoang v. Vanda Pharmaceuticals Inc., et al., No. 13-1028, D. D.C.; 2013 U.S. Dist. LEXIS 170836).

Find full version on lexis Advance®
Access this news story on lexis.com®